Company Theraclion

Equities

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:35:20 2024-05-20 am EDT			5-day change	1st Jan Change
0.46 ^EUR	-4.37%		-9.45%	+18.56%

Mar. 27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows:

- sale of equipment (66.1%);

- sale of consumables (27.8%);

- provision of after-sales services (6.1%).

Export accounts for 96.6% of net sales.

Number of employees: 30

EUR in Million	2023	Weight	Delta
Equipment 65.9 %	1	65.9 %	-
Consumables 27.7 %	1	27.7 %	-
Services 6.4 %	0	6.4 %	-

EUR in Million	2023	Weight	Delta
Germany, China, Hong Kong, Macao and United Kingdom 100.0 %	2	100.0 %	-

Managers	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	19-12-31
Laurence Géricot DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-
Jeremie Anquez CTO	Chief Tech/Sci/R&D Officer	-	-
Michel Nuta CTO	Chief Tech/Sci/R&D Officer	-	12-12-31

Members of the board	Title	Age	Since
Ari Kellen BRD	Director/Board Member	-	19-02-12
Renaud Saleur BRD	Director/Board Member	-	18-01-31
Yann Duchesne CHM	Chairman	67	22-01-23
Samuel G. Levy BRD	Director/Board Member	-	16-05-11
Mehdi El Glaoui BRD	Director/Board Member	-	21-06-21
Shawn Langer BRD	Director/Board Member	-	19-02-12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	44,263,960	31,520,939 ( 71.21 %)	22,865 ( 0.0517 %)	71.21 %

Name	Equities	%	Valuation
DNCA Finance SA 2.390 %	1,093,090	2.390 %	428 939 €
Friedland Gestion SAS 1.704 %	779,192	1.704 %	305 763 €
OFI Invest Asset Management SA 0.5727 %	261,902	0.5727 %	102 773 €
Allianz Global Investors GmbH (France) 0.001364 %	624	0.001364 %	245 €

Théraclion SA

244, avenue Pierre Brossolette

92240, Malakoff

+33 1 55 48 90 70

http://www.theraclion.fr

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERACLION	+18.56%	23.89M
THERMO FISHER SCIENTIFIC	+11.84%	227B
DANAHER CORPORATION	+15.42%	197B
INTUITIVE SURGICAL, INC.	+18.41%	141B
BOSTON SCIENTIFIC CORPORATION	+30.19%	110B
SIEMENS HEALTHINEERS AG	+0.65%	64.15B
EDWARDS LIFESCIENCES CORPORATION	+17.44%	53.72B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.82%	51.75B
AGILENT TECHNOLOGIES, INC.	+11.29%	45.2B
GE HEALTHCARE TECHNOLOGIES INC.	+5.71%	37.37B

Other Advanced Medical Equipment & Technology